Assessing the phenotypic effects in the general population of rare variants in genes for a dominant Mendelian form of diabetes
Jason Flannick(Broad Institute), David Altshuler(Massachusetts General Hospital), Christopher Newton‐Cheh(Massachusetts General Hospital), Pål R. Njølstad(Haukeland University Hospital), Alexander G. Bick(Vanderbilt University Medical Center), Vineeta Agarwala(Broad Institute), Stefan Johansson(Haukeland University Hospital), Jonathan G. Seidman(Harvard University), James B. Meigs(Broad Institute), Nicola L. Beer(Broad Institute), Jeff K. Trimmer(Pfizer (United States)), Frank Burslem, Sekar Kathiresan(Broad Institute), José C. Florez(Broad Institute), Henrik Irgens(Haukeland University Hospital), Stacey Gabriel(Broad Institute), Janne Molnes(University of Bergen), Tim Rolph(Xerox (United States)), Anders Molven(Haukeland University Hospital), Leif Groop(Broad Institute), Herman A. Taylor(Tougaloo College), Christopher J. O’Donnell(Harvard University), Valeriya Lyssenko(University of Bergen), Namrata Gupta(Broad Institute), Ervin R. Fox(Jackson Memorial Hospital), David R. Cox(Perlegen (United States)), James G. Wilson(Jackson Memorial Hospital), Noël P. Burtt(Broad Institute), Joel N. Hirschhorn(Broad Institute), M. Julia Brosnan(Albany Medical Center Hospital), Christine E. Seidman(Harvard University)
Cited by 139
Related Papers
PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
|Nature Genetics|2003|10.6k
Analysis of protein-coding genetic variation in 60,706 humans
|Nature|2016|10.3k